Cargando…
The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country
BACKGROUND/AIMS: Chronic hepatitis B (CHB) infection is a serious public health problem due to its potential liver disease sequelae and highly expensive medical costs such as the need for liver transplantation. The aim of this study was to quantify the burden of active CHB in terms of mortality and...
Autores principales: | Toy, Mehlika, Onder, Fatih Oguz, Idilman, Ramazan, Kabacam, Gokhan, Richardus, Jan Hendrik, Bozdayi, Mithat, Akdogan, Meral, Kuloglu, Zarife, Kansu, Aydan, Schalm, Solko, Yurdaydin, Cihan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427846/ https://www.ncbi.nlm.nih.gov/pubmed/22815098 http://dx.doi.org/10.1007/s10198-012-0413-8 |
Ejemplares similares
-
Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review
por: Toy, Mehlika, et al.
Publicado: (2011) -
The role of PNPLA3 (rs738409) c>g variant on histological progression of non-alcoholic fatty liver disease
por: Idilman, Ramazan, et al.
Publicado: (2020) -
ATA Index: A novel score for predicting fibrosis stage in chronic viral hepatitis
por: Yarkan Tugsal, Handan, et al.
Publicado: (2021) -
Celiac Disease: Presentation of 109 Children
por: Kuloğlu, Zarife, et al.
Publicado: (2009) -
Not all enteropathies are coeliac disease! Report of an infant with microvillus inclusion disease
por: Kozan, Eda Nur, et al.
Publicado: (2023)